NRG-CC012CD: Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment (Symon)

Sponsor:

NRG

Sponsor Study ID:

NRG-CC012CD

CTO #:

104121

NCT Number:

NCT06279013

Phase:

N/A

Protocol Type:

Health Services Research

Age Group:

Adults

Disease Sites:

Lip, Oral Cavity and Pharynx

Study Objectives:

Test the effectiveness of automated telephone system management (ATSM) + telephone interpersonal counseling (TIPC) versus active control on patient level outcome of the summary toxicity index of 24 PRO-CTCAE symptoms that include depressive, anxiety, and other symptoms commonly experienced during oral anti-cancer treatment over weeks 1-12 (immediate effect) and 13-17 (sustained effect).

eConsent:

Not available

Study Documents:

Open Study Documents
(MUSC NetID required for document access)